2022 Annual Meeting | C100 - Emerging Neuroinfectious Disease
Program Materials Program Evaluations
| 01:00 PM - 01:35 PM PDT | Speaker |
Introduction and Emerging Viruses
Daniel Pastula, MD, MHS, FÂé¶¹´«Ã½Ó³» |
| 01:00 PM - 01:00 PM PDT | Speaker |
Walk-in Slides
Daniel Pastula, MD, MHS, FÂé¶¹´«Ã½Ó³» |
| 01:35 PM - 02:10 PM PDT | Speaker |
Emerging Bacteria, Fungi, and Parasites
Felicia Chow, MD |
| 02:10 PM - 02:45 PM PDT | Speaker |
Preventing and Responding to the Next Emerging Threat
Neil Vora, MD |
| 02:45 PM - 03:00 PM PDT | Q&A |
Questions and Answers
Daniel Pastula, MD, MHS, FÂé¶¹´«Ã½Ó³», Felicia Chow, MD, Neil Vora, MD |
| Daniel Pastula, MD, MHS, FÂé¶¹´«Ã½Ó³» | Dr. Pastula has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Valneva. Dr. Pastula has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. |
| Felicia Chow, MD | Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH. |
| Neil Vora, MD | Neil Vora, MD has received personal compensation for serving as an employee of Conservation International. |